Jump to page content

Search results

  • News Calls Charité BIH Innovation Digital Labs

    BIH Digital Health Accelerator Call is open now

    Apply by November 3, 2023 to the BIH Digital Health Accelerator Program, which provides funding to help you translate your digital health venture.

  • Press release

    Liver fibrosis: giant cells step in to compensate for impaired immune function

    A team of researchers has uncovered a previously unknown compensatory mechanism found in liver disease. If Kupffer cells (KCs), a specific kind of immune cells found in the liver, become impaired by tissue scarring, immune cells originating in the bone marrow flow to the organ, where they form larger cell clusters to perform the same function.…

  • News

    iRISE to Improve Reproducibility of Scientific Research

    A new project funded by the European Union’s Horizon Europe research and innovation programme will develop a framework to improve the reproducibility of scientific research. The project, called iRISE (improving Reproducibility in SciencE), will bring together experts from academia and industry to develop a comprehensive understanding of the drivers…

  • Press release

    Genes as a key to new therapies: Maik Pietzner receives ERC Starting Grant

    In the fight against many common diseases, there is a huge need for safe and effective drugs. Maik Pietzner, a group leader in the Computational Medicine Group at the Berlin Institute of Health at Charité (BIH), sees genes as a key to developing new therapies, because most diseases have a genetic background. Using a sophisticated strategy that…

  • Press release

    Rare kidney disease is genetically decoded

    Bartter syndrome type 3 is the result of several structural variants in the genome. By using long-read sequencing, Janine Altmüller and her team from the Max Delbrück Center, the Berlin Institute of Health at Charité (BIH) and University Hospital Cologne mapped out the rare disease in unprecedented detail. They have now reported their findings in…

  • News

    Genome analyses up to 14 times faster with Cloud

    In a proof-of-concept test, researchers at the Berlin Institute of Health at Charité (BIH), together with industry partners intel and Sentieon, have been able to increase the speed of computationally intensive genome analyses by up to 14 times. The special feature: Long-read single-cell sequencing was performed via a dedicated cloud rather than…

  • Press release  Illustration of the SARS-CoV-2 spike

    Low binding affinity improves vaccine efficacy

    Conventional vaccines usually contain antigens – components of the respective pathogens – that bind to receptors on the surface of their target cells in order to trigger the disease. Scientists at the Berlin Institute of Health at Charité (BIH) and the Max Delbrück Center have now discovered that antigen variants with low receptor binding can be…

  • News

    Young BIH scientists attend 72nd Lindau Nobel Laureate Meeting

    The Lindau Nobel Laureate Meetings are annual conferences where some of the brightest minds in science converge to exchange knowledge, foster collaboration, and inspire the next generation of researchers. This year, two young researchers from the BIH took part in the 72nd Lindau Nobel Laureate Meeting that was dedicated to Physiology and Medicine.…

Press contact

Pressekontakt / Press contact

Katharina Kalhoff: +49 1515 7579574

Ole Kamm: +49 1522 5610126

Contact information